SEC ownership of Medinotec Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001931055.

Comparable stake leader

Gregory Vizirgianakis

Disclosed value leader

Comparable rows

3/4

Latest evidence

16 Apr 2025

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
3 of 4
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Gregory Vizirgianakis
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
16 Apr 2025
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001931055
Issuer location
Johannesburg

Ownership snapshot

Top shareholders of Medinotec Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gregory Vizirgianakis
Disclosed value leader
Comparable rows
3/4
Latest evidence
16 Apr 2025
3/4/5 13D/G Lead comparable stake: 40% 1 rows are not safely comparable across share classes. 13D/G row: Gregory Vizirgianakis

Quick read

Gregory Vizirgianakis leads the comparable SEC ownership view at 40%.

3 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gregory Vizirgianakis's linked filing trail.
Comparable ownership Top 3
Gregory Vizirgianakis 40%
Stavros G. Vizirgianakis 40%
Athanasios Spirakis 0.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gregory Vizirgianakis
3/4/5 13D/G
President, Secretary, CEO, Director, 10%+ Owner
40%
from 13D/G
4,750,179 shares
16 Apr 2025
Stavros G. Vizirgianakis
3/4/5 13D/G
Director, 10%+ Owner
40%
from 13D/G
4,750,179 shares
16 Apr 2025
Athanasios Spirakis
3/4/5
Director
0.1%
12,073 shares
16 Apr 2025
Pieter Mohr van Niekerk
3/4/5
CFO, Director
class O/S missing
401,965 shares
16 Apr 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-5 of 5 reporting-owner rows connected to Medinotec Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
5
Largest Forms 3/4/5 holder
Athanasios Spirakis
Net 12M change
$0
Latest report
16 Apr 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Athanasios Spirakis Director Mixed 16 Apr 2025
Stavros G. Vizirgianakis Director, 10%+ Owner Mixed 16 Apr 2025
Gregory Vizirgianakis President, Secretary, CEO, Director, 10%+ Owner Mixed 16 Apr 2025
Pieter Mohr van Niekerk CFO, Director Mixed 16 Apr 2025
Joseph P. Dwyer Director Mixed 16 Apr 2025

Recent insider transactions for Medinotec Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .